Delivery Order V797D70090-75D30126F21487

The Centers for Disease Control and Prevention (CDC Pittsburgh) issued a delivery order to Quest Diagnostics Incorporated on September 27, 2024, under the Test Surge and Data Sharing IDIQ with a ceiling value of $3.636 million for clinical laboratory testing services. Place of performance is Secaucus, NJ. The order is firm fixed price with an ultimate completion date of September 26, 2029. In FY2025, Quest Diagnostics invoiced $1.1 million against this order, deploying 2.7 FTEs with no...

The CDC Pittsburgh issued a $14.0 million delivery order to Quest Diagnostics Incorporated on July 30, 2020, for surge serology testing with an ultimate completion date of November 19, 2020. Place of performance is Secaucus, NJ. The order is priced on a firm fixed-price basis with no set-aside. Service Contract Inventory reporting for FY2021 records $14 million invoiced across 33.7 FTEs and 70,119 contractor hours, reflecting a derived hourly rate of $200.00 per hour. Quest Diagnostics...

This is a $24,691,200 firm-fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Quest Diagnostics Incorporated for serology testing services. The contract has a period of performance through March 5, 2022 and was awarded on November 13, 2020 without any set-aside designation. Quest Diagnostics, a for-profit diagnostic information services provider, has previously supported federal agencies such as the Department of Justice's Bureau of Prisons, the...

The Centers for Disease Control and Prevention (CDC) Pittsburgh issued a delivery order to Quest Diagnostics Incorporated on September 27, 2024, under the Test Surge and Data Sharing IDIQ with a ceiling value of $6,631,042.24. The Test Surge and Data Sharing is a multiple-award IDIQ. Place of performance is Secaucus, NJ. The order is firm fixed price with an ultimate completion date of September 26, 2029. In FY2025, Quest Diagnostics invoiced $1.2 million against this order with 2.8 FTEs,...

The Centers for Disease Control and Prevention awarded a firm-fixed price contract valued at $1,676,070.04 to Quest Diagnostics Clinical Laboratories, Inc. to meet requirements established in a January 2020 solicitation. The solicitation sought longitudinal laboratory test order and result data for hosting in CDC's Data Hub to support analyses of public health trends related to reportable diseases and exposures over time. Only Quest could fulfill this requirement due to its market share and...

<p>CDC Pittsburgh awarded a purchase order to Quest Diagnostics Incorporated for delivery of deidentified nasopharyngeal specimens, valued at $93,600.00, on August 14, 2024. Work is performed at Halethorpe, Maryland. The order carries a firm fixed price structure with an ultimate completion date of August 13, 2026. This is a commercial acquisition under no set-aside, issued in execution of Executive Order 14398.</p>

Quest Diagnostics Incorporated has been awarded a firm fixed price, definitive contract valued at twenty-one million, seven hundred ninety-five thousand, twenty-six dollars by the Centers for Disease Control and Prevention to provide MASS-C serology services. Performance will take place in Secaucus, New Jersey with a completion date of December 11, 2023. No set-aside designation was used for this solicitation. As a leading provider of diagnostic information services, Quest Diagnostics will...

This contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Quest Diagnostics Incorporated, a for-profit diagnostic information services provider, for data submission services. The contract is a definitive, firm fixed-price contract with a potential value of $722,500.00. The purpose is to obtain laboratory test order and test result data, including longitudinal patient identifiers but without personally identifiable information, to...

This is a $325,072 delivery order awarded to Quest Diagnostics Incorporated by the Centers for Disease Control and Prevention (CDC) for H5N1 test development services. The order was issued under the Test Surge and Data Sharing indefinite delivery, indefinite quantity (IDIQ) contract, which provides a vehicle for the CDC to procure specialized clinical laboratory testing and analysis on an as-needed basis. Quest Diagnostics is a for-profit organization that has provided laboratory testing...

<p>The Food and Drug Administration issued a delivery order to Laboratory Corporation of America (Labcorp) on July 13, 2023, with a ceiling value of $30,218.76, under the GSA Federal Supply Schedule for Medical Laboratory Testing and Analysis Services (FSS-621-II) to provide COVID-19 testing for FDA employees and contractors.</p> <p>Place of performance is Silver Spring, Maryland. The order has a firm fixed price and an ultimate completion date of July 18, 2027. No set-aside was used.</p>